My Watchlist Items
- No Watchlist
Global Blood Therapeutics, Inc. (GBT)
66.71 0.13999939(+0.21030402%)
| Title | Name | Pay | Currency Pay | Gender | Year Born | Title Since |
|---|---|---|---|---|---|---|
| Senior Director of Corporation Communications & Investor Relations | Stephanie Yao | N/A | USD | N/A | N/A | |
| Senior Vice President of Operations | Ms. Nazila Habibizad | N/A | USD | female | N/A | N/A |
| Founder & Advisor | Dr. Andrej Sali Ph.D. | N/A | USD | N/A | N/A | |
| Founder & Advisor | Dr. Matthew P. Jacobson Ph.D. | N/A | USD | N/A | N/A | |
| Founder & Advisor | Dr. David R. Phillips | N/A | USD | N/A | N/A | |
| Chief Commercial Officer | Mr. David L. Johnson | 702750 | USD | male | 1969 | N/A |
| Chief Bus. & Strategy Officer | Ms. Jung E. Choi | 657120 | USD | female | 1970 | N/A |
| Chief Legal Officer & Sec. | Ms. Patricia Borga Suvari | 641500 | USD | female | 1961 | N/A |
| Chief Financial Officer & Principal Accounting Officer | Mr. Jeffrey S. Farrow | 694310 | USD | male | 1962 | N/A |
| Pres, Chief Executive Officer & Director | Dr. Ted W. Love | 1130000 | USD | 1959 | N/A |
| Symbol | Date | Rating | Rating Score | Rating Details |
|---|---|---|---|---|
| GBT | 11 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 9 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 8 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 5 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 4 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 3 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 2 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 1 August, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 29 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 28 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 27 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 26 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 25 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 22 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 21 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 20 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 19 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 18 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 15 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 14 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 13 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 12 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 11 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 8 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 7 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 6 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 5 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 1 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 30 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 29 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 28 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 27 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 24 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 23 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 22 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 21 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 17 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 16 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 15 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 14 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 13 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 10 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 9 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 8 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 7 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 6 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 3 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 2 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 1 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 31 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 27 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 26 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 25 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 24 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 23 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 20 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 19 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 18 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 17 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 16 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 13 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 12 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 11 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 10 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 9 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 6 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 5 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 4 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 3 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 29 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 28 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 27 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 26 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 25 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 22 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 21 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 20 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 19 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 18 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 15 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 14 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 13 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 12 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 11 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 8 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 7 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 6 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 5 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 4 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 1 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 31 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 30 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 29 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 28 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 25 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 24 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 23 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 22 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 21 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| GBT | 18 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Neutral) Rating DE: (Strong Buy) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| Holder | Shares | Date Reported | Change |
|---|---|---|---|
| SHELL ASSET MANAGEMENT CO | 2769 | 30 June, 2022 | 10 |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 44 | 30 June, 2022 | 0 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 9303 | 30 June, 2022 | -2721 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 80948 | 30 June, 2022 | 0 |
| SWISS NATIONAL BANK | 145100 | 30 June, 2022 | 8000 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 242142 | 30 June, 2022 | -25340 |
| WASHINGTON TRUST ADVISORS, INC. | 102 | 30 June, 2022 | 0 |
| CREWE ADVISORS LLC | 191 | 30 June, 2022 | 191 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 7921 | 30 June, 2022 | -5005 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 951111 | 30 June, 2022 | 308207 |
| ARGENT TRUST CO | 12984 | 30 June, 2022 | 3700 |
| AIGEN INVESTMENT MANAGEMENT, LP | 17773 | 30 June, 2022 | 17773 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 123415 | 30 June, 2022 | -7936 |
| PICTET ASSET MANAGEMENT SA | 92166 | 30 June, 2022 | 41568 |
| ALPS ADVISORS INC | 38620 | 30 June, 2022 | 38620 |
| TORTOISE INVESTMENT MANAGEMENT, LLC | 1267 | 30 June, 2022 | 0 |
| ADVISOR GROUP HOLDINGS, INC. | 817 | 30 June, 2022 | -575 |
| DEKABANK DEUTSCHE GIROZENTRALE | 24250 | 30 June, 2022 | 0 |
| CUTLER GROUP LP | 1242 | 30 June, 2022 | -16295 |
| SEVEN EIGHT CAPITAL, LP | 8893 | 30 June, 2022 | 8893 |
| NEW YORK STATE COMMON RETIREMENT FUND | 44947 | 30 June, 2022 | 1395 |
| FRANKLIN RESOURCES INC | 469444 | 30 June, 2022 | -137882 |
| HANDELSBANKEN FONDER AB | 12644 | 30 June, 2022 | 0 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 20097 | 30 June, 2022 | 20097 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 44436 | 30 June, 2022 | -147 |
| OPPENHEIMER & CO INC | 12764 | 30 June, 2022 | 1015 |
| US BANCORP \DE\ | 44 | 30 June, 2022 | -359 |
| ARIZONA STATE RETIREMENT SYSTEM | 16688 | 30 June, 2022 | 1010 |
| BAILLIE GIFFORD & CO | 835 | 30 June, 2022 | 0 |
| RHUMBLINE ADVISERS | 73445 | 30 June, 2022 | 8466 |
| CWM, LLC | 103 | 30 June, 2022 | 10 |
| METROPOLITAN LIFE INSURANCE CO/NY | 3921 | 30 June, 2022 | 0 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 4333 | 30 June, 2022 | -38371 |
| UBS GROUP AG | 108487 | 30 June, 2022 | -22618 |
| MIZUHO MARKETS AMERICAS LLC | 188281 | 30 June, 2022 | -78233 |
| OLD NATIONAL BANCORP /IN/ | 11486 | 30 June, 2022 | 11486 |
| ALPHACREST CAPITAL MANAGEMENT LLC | 10021 | 30 June, 2022 | 10021 |
| TREXQUANT INVESTMENT LP | 6672 | 30 June, 2022 | -4588 |
| RICE HALL JAMES & ASSOCIATES, LLC | 231435 | 30 June, 2022 | -152317 |
| SATTER MANAGEMENT CO., L.P. | 126270 | 30 June, 2022 | 0 |
| PRINCIPAL FINANCIAL GROUP INC | 16943 | 30 June, 2022 | -27686 |
| TCI WEALTH ADVISORS, INC. | 278 | 30 June, 2022 | 74 |
| SUGARLOAF WEALTH MANAGEMENT, LLC | 150 | 30 June, 2022 | 0 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 110 | 30 June, 2022 | -65 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 17644 | 30 June, 2022 | 4975 |
| DEUTSCHE BANK AG\ | 209310 | 30 June, 2022 | 26906 |
| HUNTINGTON NATIONAL BANK | 1785 | 30 June, 2022 | 528 |
| BANQUE PICTET & CIE SA | 41898 | 30 June, 2022 | -4037 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 200 | 30 June, 2022 | 0 |
| DAIWA SECURITIES GROUP INC. | 214 | 30 June, 2022 | 0 |
| WEDBUSH SECURITIES INC | 6472 | 30 June, 2022 | 6472 |
| LINDBROOK CAPITAL, LLC | 50 | 30 June, 2022 | 23 |
| QUADRANT CAPITAL GROUP LLC | 28 | 30 June, 2022 | -25 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 33172 | 30 June, 2022 | -1231 |
| QUANTBOT TECHNOLOGIES LP | 6810 | 30 June, 2022 | 5064 |
| SG AMERICAS SECURITIES, LLC | 48708 | 30 June, 2022 | 38996 |
| TRUVESTMENTS CAPITAL LLC | 300 | 30 June, 2022 | 300 |
| WINTON GROUP LTD | 23397 | 30 June, 2022 | 3812 |
| WALLEYE CAPITAL LLC | 106796 | 30 June, 2022 | 40197 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 61589 | 30 June, 2022 | 54486 |
| JUMP FINANCIAL, LLC | 34974 | 30 June, 2022 | 34974 |
| PROSHARE ADVISORS LLC | 12069 | 30 June, 2022 | -6255 |
| RONALD BLUE TRUST, INC. | 621 | 30 June, 2022 | 621 |
| TD ASSET MANAGEMENT INC | 64808 | 30 June, 2022 | -7666 |
| VICTORY CAPITAL MANAGEMENT INC | 7134 | 30 June, 2022 | -18 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 202750 | 30 June, 2022 | -7225 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 430 | 30 June, 2022 | 165 |
| SANDERS MORRIS HARRIS LLC | 6500 | 30 June, 2022 | -6500 |
| EULAV ASSET MANAGEMENT | 380000 | 30 June, 2022 | -45000 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 26934 | 30 June, 2022 | -1130 |
| CANDRIAM S.C.A. | 779691 | 30 June, 2022 | 22983 |
| JPMORGAN CHASE & CO | 406113 | 30 June, 2022 | 220883 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 3336 | 30 June, 2022 | 659 |
| ASSENAGON ASSET MANAGEMENT S.A. | 168770 | 30 June, 2022 | 168770 |
| NISA INVESTMENT ADVISORS, LLC | 2110 | 30 June, 2022 | 600 |
| ROOSEVELT INVESTMENT GROUP LLC | 802390 | 30 June, 2022 | 205543 |
| CITIGROUP INC | 189084 | 30 June, 2022 | 143381 |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 94062 | 31 March, 2022 | -20247 |
| BELLEVUE ASSET MANAGEMENT, LLC | 40 | 31 March, 2022 | -8 |
| CAPTRUST FINANCIAL ADVISORS | 261 | 31 March, 2022 | -845 |
| NUVEEN ASSET MANAGEMENT, LLC | 282374 | 31 March, 2022 | 1510 |
| ROYAL BANK OF CANADA | 352086 | 31 March, 2022 | 274497 |
| CASDIN CAPITAL, LLC | 1325000 | 31 March, 2022 | 0 |
| CRESTLINE MANAGEMENT, LP | 35295 | 31 March, 2022 | 0 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 232992 | 31 March, 2022 | 9086 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 435500 | 31 March, 2022 | 13793 |
| CAPITAL FUND MANAGEMENT S.A. | 95307 | 31 March, 2022 | 82986 |
| QUINN OPPORTUNITY PARTNERS LLC | 324494 | 31 March, 2022 | 324494 |
| KIWI WEALTH INVESTMENTS LIMITED PARTNERSHIP | 72433 | 31 March, 2022 | 16611 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 59113 | 31 March, 2022 | -136253 |
| MORGAN STANLEY | 568538 | 31 March, 2022 | 367681 |
| BLACKROCK INC. | 5284511 | 31 March, 2022 | -68545 |
| D. E. SHAW & CO., INC. | 13402 | 31 March, 2022 | -13421 |
| VIRTUS ETF ADVISERS LLC | 14938 | 31 March, 2022 | 0 |
| PURA VIDA INVESTMENTS, LLC | 29454 | 31 March, 2022 | 29454 |
| FORA CAPITAL, LLC | 8005 | 31 March, 2022 | 8005 |
| AFFINITY ASSET ADVISORS, LLC | 70000 | 31 March, 2022 | 70000 |
| IKARIAN CAPITAL, LLC | 49997 | 31 March, 2022 | -114085 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 75 | 31 March, 2022 | 75 |
| JANE STREET GROUP, LLC | 211392 | 31 March, 2022 | 97073 |
| CAPITAL IMPACT ADVISORS, LLC | 29001 | 31 March, 2022 | 6540 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 10891 | 31 March, 2022 | -26899 |
| ORBIMED ADVISORS LLC | 1576600 | 31 March, 2022 | 1576600 |
| POINT72 ASSET MANAGEMENT, L.P. | 920200 | 31 March, 2022 | 736729 |
| STATE OF WYOMING | 214 | 31 March, 2022 | 41 |
| VOYA INVESTMENT MANAGEMENT LLC | 24395 | 31 March, 2022 | 936 |
| EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC | 17321627 | 31 March, 2022 | 17321627 |
| SATTER MANAGEMENT CO., L.P. | 126270 | 31 March, 2022 | 0 |
| ENGINEERS GATE MANAGER LP | 27945 | 31 March, 2022 | 3668 |
| WALLEYE TRADING LLC | 4663 | 31 March, 2022 | 4663 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 7859 | 31 March, 2022 | 571 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 76330 | 31 March, 2022 | -4888 |
| JEFFERIES GROUP LLC | 13898 | 31 March, 2022 | -5994 |
| SCHONFELD STRATEGIC ADVISORS LLC | 41579 | 31 March, 2022 | -51961 |
| KYNAM CAPITAL MANAGEMENT, LP | 1339322 | 31 March, 2022 | 346373 |
| TWO SIGMA INVESTMENTS, LP | 438080 | 31 March, 2022 | 246575 |
| WALLEYE CAPITAL LLC | 66599 | 31 March, 2022 | 66599 |
| PERCEPTIVE ADVISORS LLC | 3892493 | 31 March, 2022 | 442578 |
| BAKER BROS. ADVISORS LP | 3314765 | 31 March, 2022 | 0 |
| MILLENNIUM MANAGEMENT LLC | 312043 | 31 March, 2022 | -42547 |
| JANUS HENDERSON GROUP PLC | 5603255 | 31 March, 2022 | 120091 |
| ALGERT GLOBAL LLC | 25598 | 31 March, 2022 | 12413 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 17600 | 31 March, 2022 | 17600 |
| AMERITAS INVESTMENT PARTNERS, INC. | 4693 | 31 March, 2022 | 0 |
| ENDURANT CAPITAL MANAGEMENT LP | 43250 | 31 March, 2022 | 453 |
| SQUAREPOINT OPS LLC | 75578 | 31 March, 2022 | 32148 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3181299 | 31 March, 2022 | -79386 |
| STATE STREET CORP | 3456012 | 31 March, 2022 | 284877 |
| DSC ADVISORS, L.P. | 160000 | 31 March, 2022 | 0 |
| WELLS FARGO & COMPANY/MN | 289084 | 31 March, 2022 | 128489 |
| MIZUHO MARKETS AMERICAS LLC | 266514 | 31 March, 2022 | 266514 |
| ALLIANCEBERNSTEIN L.P. | 71702 | 31 March, 2022 | 200 |
| AMERICAN CENTURY COMPANIES INC | 352335 | 31 March, 2022 | -1410 |
| FIRST TRUST ADVISORS LP | 48807 | 31 March, 2022 | 29090 |
| OVATA CAPITAL MANAGEMENT LTD | 21996 | 31 March, 2022 | -3768 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 150800 | 31 March, 2022 | 150800 |
| AMUNDI | 4172 | 31 March, 2022 | 0 |
| HIGHVISTA STRATEGIES LLC | 51085 | 31 March, 2022 | 51085 |
| GYON TECHNOLOGIES CAPITAL MANAGEMENT, LP | 13199 | 31 March, 2022 | -14813 |
| E FUND MANAGEMENT CO., LTD. | 9646 | 31 March, 2022 | 9646 |
| WEISS MULTI-STRATEGY ADVISERS LLC | 8000 | 31 March, 2022 | -17414 |
| BARCLAYS PLC | 61038 | 31 March, 2022 | -14150 |
| GEODE CAPITAL MANAGEMENT, LLC | 1086624 | 31 March, 2022 | 12589 |
| J. GOLDMAN & CO LP | 114092 | 31 March, 2022 | 114092 |
| FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. | 19738 | 31 March, 2022 | -2289 |
| ALTIUM CAPITAL MANAGEMENT LP | 54000 | 31 March, 2022 | 0 |
| NATIXIS | 604200 | 31 March, 2022 | 162620 |
| MACQUARIE GROUP LTD | 3298 | 31 March, 2022 | 0 |
| RAYMOND JAMES & ASSOCIATES | 6373 | 31 March, 2022 | -562 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1601 | 31 March, 2022 | -2688 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 9312 | 31 March, 2022 | 0 |
| TWINBEECH CAPITAL LP | 56322 | 31 March, 2022 | 7543 |
| RAFFERTY ASSET MANAGEMENT, LLC | 195293 | 31 March, 2022 | 1429 |
| LOGOS GLOBAL MANAGEMENT LP | 1250000 | 31 March, 2022 | 500000 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 1182307 | 31 March, 2022 | 439307 |
| AQUATIC CAPITAL MANAGEMENT LLC | 300 | 31 March, 2022 | 300 |
| FOURTHOUGHT FINANCIAL, LLC | 1055 | 31 March, 2022 | 0 |
| ELEQUIN CAPITAL LP | 59 | 31 March, 2022 | 59 |
| AMALGAMATED FINANCIAL CORP. | 10100 | 31 March, 2022 | 10100 |
| POLAR CAPITAL HOLDINGS PLC | 1095810 | 31 March, 2022 | 175000 |
| CITADEL ADVISORS LLC | 1965932 | 31 March, 2022 | 280076 |
| SKYVIEW INVESTMENT ADVISORS, LLC | 804 | 31 March, 2022 | 687 |
| PARADIGM BIOCAPITAL ADVISORS LP | 966827 | 31 March, 2022 | 186347 |
| DEEP TRACK CAPITAL, LP | 2304683 | 31 March, 2022 | 304683 |
| FIDUCIARY TRUST CO | 11550 | 31 March, 2022 | 0 |
| SIENA CAPITAL LLC | 25 | 31 March, 2022 | 25 |
| LEGAL & GENERAL GROUP PLC | 51616 | 31 March, 2022 | 1918 |
| AMERIPRISE FINANCIAL INC | 13559 | 31 March, 2022 | -21846 |
| NOMURA HOLDINGS INC | 118200 | 31 March, 2022 | 118200 |
| GABELLI FUNDS LLC | 19000 | 31 March, 2022 | 0 |
| ANCORA ADVISORS, LLC | 1050 | 31 March, 2022 | 0 |
| BANK OF NEW YORK MELLON CORP | 272603 | 31 March, 2022 | 876 |
| CREDIT SUISSE AG/ | 58415 | 31 March, 2022 | 3982 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 54955 | 31 March, 2022 | -73037 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1501382 | 31 March, 2022 | 225582 |
| MOORE CAPITAL MANAGEMENT, LP | 19501 | 31 March, 2022 | 19501 |
| PNC FINANCIAL SERVICES GROUP, INC. | 1928 | 31 March, 2022 | -1985 |
| ENSIGN PEAK ADVISORS, INC | 18110 | 31 March, 2022 | -55542 |
| UBS ASSET MANAGEMENT AMERICAS INC | 76474 | 31 March, 2022 | 1349 |
| FARALLON CAPITAL MANAGEMENT LLC | 169458 | 31 March, 2022 | 83004 |
| AMERICAN INTERNATIONAL GROUP, INC. | 30755 | 31 March, 2022 | -2164 |
| ARCHPOINT INVESTORS | 177789 | 31 March, 2022 | -16000 |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151800 | 31 March, 2022 | 57000 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 13750 | 31 March, 2022 | 3000 |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 16950 | 31 March, 2022 | 2150 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 39118 | 31 March, 2022 | 7798 |
| CANTOR FITZGERALD, L. P. | 6000 | 31 March, 2022 | 6000 |
| GOLDMAN SACHS GROUP INC | 1833720 | 31 March, 2022 | 595983 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 12926 | 31 March, 2022 | 12926 |
| BANK OF AMERICA CORP /DE/ | 1817187 | 31 March, 2022 | 260871 |
| PANAGORA ASSET MANAGEMENT INC | 95374 | 31 March, 2022 | 5086 |
| WELLINGTON MANAGEMENT GROUP LLP | 34861 | 31 March, 2022 | -7245 |
| NORTHERN TRUST CORP | 586397 | 31 March, 2022 | -22881 |
| AMALGAMATED BANK | 10100 | 31 March, 2022 | -688 |
| INVESCO LTD. | 39503 | 31 March, 2022 | 308 |
| VANGUARD GROUP INC | 6024262 | 31 March, 2022 | 31120 |
| TUDOR INVESTMENT CORP ET AL | 13027 | 31 March, 2022 | -44919 |
| TAYLOR WEALTH MANAGEMENT PARTNERS | 29615 | 31 March, 2022 | -572 |
| THRIVENT FINANCIAL FOR LUTHERANS | 53484 | 31 March, 2022 | -55 |
| FMR LLC | 4091699 | 31 March, 2022 | -190702 |
| GROUP ONE TRADING, L.P. | 9656 | 31 March, 2022 | 9656 |
| DIMENSIONAL FUND ADVISORS LP | 530693 | 31 March, 2022 | 111130 |
| DAIWA SECURITIES GROUP INC. | 214 | 31 March, 2022 | 0 |
| STIFEL FINANCIAL CORP | 6113 | 31 March, 2022 | -18303 |
| TWO SIGMA ADVISERS, LP | 88200 | 31 March, 2022 | 88200 |
| STATE OF WISCONSIN INVESTMENT BOARD | 77400 | 31 March, 2022 | 0 |
| Holder | Shares | Date Reported | Weight Percent |
|---|---|---|---|
| CAPITAL FUND MANAGEMENT S.A. | 103138 | 30 June, 2022 | N/A |
| State of New Jersey Common Pension Fund D | 80948 | 30 June, 2022 | N/A |
| DIMENSIONAL FUND ADVISORS LP | 89414 | 30 June, 2022 | N/A |
| NEW YORK STATE COMMON RETIREMENT FUND | 44947 | 30 June, 2022 | N/A |
| E Fund Management Co., Ltd. | 9646 | 31 March, 2022 | N/A |
| Fairmount Funds Management LLC | 1182307 | 31 March, 2022 | N/A |
| GABELLI FUNDS LLC | 19000 | 31 March, 2022 | N/A |
| BOOTHBAY FUND MANAGEMENT, LLC | 18695 | 31 December, 2021 | N/A |
| Verition Fund Management LLC | 41989 | 30 September, 2021 | N/A |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1067 | 30 June, 2021 | N/A |
| Harvest Fund Management Co., Ltd | 154 | 31 March, 2021 | N/A |
| SPDR S&P Biotech ETF | 885315 | 31 August, 2020 | 0.99 |
| iShares Russell Mid-Cap ETF | 155486 | 31 August, 2020 | 0.05 |
| Handelsbanken Gl Smabolag Index Crit(A1 SEK) | 12644 | 31 August, 2020 | 0.07 |
| Nuveen ESG Small-Cap ETF | 12772 | 31 August, 2020 | 0.25 |
| Principal Healthcare Innovators Index ETF | 13632 | 31 August, 2020 | 0.85 |
| SEI Inst Inv Extended Market Index Fund | 15001 | 31 August, 2020 | 0.07 |
| iShares Russell 3000 ETF | 17302 | 31 August, 2020 | 0.01 |
| iShares NASDAQ Biotechnology ETF | 624939 | 31 August, 2020 | 0.41 |
| iShares NASDAQ US Biotechnology UCITS ETF | 17533 | 31 August, 2020 | 0.41 |
| CSIF (CH) III Equity World ex CH Small Cap Blue - Pension Fund | 18415 | 31 August, 2020 | 0.06 |
| iShares Morningstar Small-Cap Growth ETF | 19792 | 31 August, 2020 | 0.47 |
| Fidelity MSCI Health Care Index ETF | 23614 | 31 August, 2020 | 0.07 |
| John Hancock Multifactor Small Cap ETF | 25436 | 31 August, 2020 | 0.32 |
| Schwab U.S. Broad Market ETF | 28857 | 31 August, 2020 | 0.01 |
| iShares Russell 1000 ETF | 44335 | 31 August, 2020 | 0.01 |
| Direxion Daily S&P Biotech Bull 3X Shares | 37877 | 31 August, 2020 | 0.56 |
| iShares Core S&P Total U.S. Stock Market ETF | 47955 | 31 August, 2020 | 0.01 |
| Vanguard Total Stock Market Index Fund | 1728270 | 31 August, 2020 | 0.01 |
| ALPS Medical Breakthroughs ETF | 79476 | 31 August, 2020 | 2.77 |
| PARVEST Health Care Innovators | 88068 | 31 August, 2020 | 0.78 |
| BNP Paribas US Small Cap | 149732 | 31 August, 2020 | 1.55 |
| CSIF (CH) Equity World ex CH Small Cap Blue | 11910 | 31 August, 2020 | 0.06 |
| iShares Russell Mid-Cap Growth ETF | 276259 | 31 August, 2020 | 0.13 |
| Vanguard Health Care Index Fund | 151176 | 31 August, 2020 | 0.07 |
| Schwab U.S. Small-Cap ETF | 221475 | 31 August, 2020 | 0.14 |
| iShares Russell 1000 Growth ETF | 208888 | 31 August, 2020 | 0.02 |
| Fidelity Advisor Biotechnology Fund | 482618 | 31 July, 2020 | 1.4 |
| Vanguard Small-Cap Index Fund | 1513730 | 31 July, 2020 | 0.11 |
| Fidelity OTC Portfolio | 1275360 | 31 July, 2020 | 0.37 |
| Fidelity Select Biotechnology Portfolio | 1202020 | 31 July, 2020 | 1.15 |
| Vanguard Small-Cap Growth Index Fund | 921718 | 31 July, 2020 | 0.23 |
| Fidelity Blue Chip Growth Fund | 899959 | 31 July, 2020 | 0.17 |
| Vanguard Extended Market Index Fund | 870302 | 31 July, 2020 | 0.08 |
| Fidelity Balanced Fund | 663421 | 31 July, 2020 | 0.19 |
| Fidelity Contrafund | 661499 | 31 July, 2020 | 0.04 |
| Franklin Small Cap Growth Fund | 463200 | 31 July, 2020 | 1.1 |
| Franklin Templeton Investment Funds -Biotechnology Discovery | 389800 | 31 July, 2020 | 1.51 |
| JPMorgan Small Cap Growth Fund | 371719 | 31 July, 2020 | 0.59 |
| Strategic Advisers Fidelity US Total Stock Fund | 357324 | 31 July, 2020 | 0.07 |
| Invesco Oppenheimer Discovery Fund | 299518 | 31 July, 2020 | 0.6 |
| Franklin Biotechnology Discovery Fund | 295200 | 31 July, 2020 | 1.46 |
| Franklin Small-Mid Cap Growth Fund | 295000 | 31 July, 2020 | 0.48 |
| Fidelity Extended Market Index Fund | 290354 | 31 July, 2020 | 0.08 |
| Hartford Healthcare Fund | 192915 | 31 July, 2020 | 0.91 |
| AMG TimesSquare Mid Cap Growth Fund | 186500 | 31 July, 2020 | 0.67 |
| Fidelity Select Pharmaceuticals Portfolio | 181100 | 31 July, 2020 | 1.42 |
| Fidelity Series Blue Chip Growth Fund | 161895 | 31 July, 2020 | 0.19 |
| Wells Fargo Master Trust Small Company Growth | 141138 | 31 July, 2020 | 0.69 |
| Invesco Health Care Fund | 126658 | 31 July, 2020 | 0.58 |
| Neuberger Berman Mid Cap Growth Fund | 125000 | 31 July, 2020 | 0.54 |
| Fidelity Advisor New Insights Fund | 109578 | 31 July, 2020 | 0.03 |
| Fidelity Mid Cap Index Fund | 106466 | 31 July, 2020 | 0.05 |
| Fidelity Total Market Index Fund | 92706 | 31 July, 2020 | 0.01 |
| Fidelity VIP III Balanced Portfolio | 89969 | 31 July, 2020 | 0.18 |
| Fidelity Blue Chip Growth K6 Fund | 88880 | 31 July, 2020 | 0.16 |
| CREF Stock Account | 84088 | 31 July, 2020 | 0.01 |
| Fidelity Advisor Balanced Fund | 81429 | 31 July, 2020 | 0.18 |
| Fidelity VIP Contrafund Portfolio | 74539 | 31 July, 2020 | 0.03 |
| Vanguard Institutional Total Stock Market Index Fund | 72573 | 31 July, 2020 | 0.01 |
| Fidelity Contrafund K6 Fund | 71520 | 31 July, 2020 | 0.03 |
| AMG TimesSquare Small Cap Growth Fund | 69764 | 31 July, 2020 | 1.11 |
| Principal SmallCap Growth Fund I | 67232 | 31 July, 2020 | 0.22 |
| Neuberger Berman Small Cap Growth Fund | 66000 | 31 July, 2020 | 1.57 |
| Fidelity Advisor Growth Opportunities Fund | 65300 | 31 July, 2020 | 0.03 |
| DWS Biotech | 60000 | 31 July, 2020 | 0.8 |
| Hartford Small Company Fund | 55727 | 31 July, 2020 | 0.58 |
| Driehaus US Micro Cap Equity Fund | 54782 | 31 July, 2020 | 0.7 |
| Fidelity OTC K6 Portfolio | 52885 | 31 July, 2020 | 0.35 |
| JPMorgan U.S. Small Company Fund | 51700 | 31 July, 2020 | 0.4 |
| Vanguard Balanced Index Fund | 51225 | 31 July, 2020 | 0.01 |
| Transamerica T. Rowe Price Small Cap VP | 50604 | 31 July, 2020 | 0.35 |
| AST Fidelity Institutional AMsm Quantitative Portfolio | 50527 | 31 July, 2020 | 0.16 |
| John Hancock New Opportunities Fund | 50387 | 31 July, 2020 | 1.13 |
| Advanced Srs T Rowe Price Asset Allocation Port | 49300 | 31 July, 2020 | 0.04 |
| TIAA-CREF Equity Index Fund | 47293 | 31 July, 2020 | 0.01 |
| Fidelity Series Total Market Index Fund | 45564 | 31 July, 2020 | 0.01 |
| Neuberger Berman AMT Mid-Cap Growth Portfolio | 45000 | 31 July, 2020 | 0.58 |
| Invesco NASDAQ Biotech UCITS ETF | 43197 | 31 July, 2020 | 0.45 |
| Fidelity VIP Growth Portfolio | 40500 | 31 July, 2020 | 0.04 |
| Fidelity Series Opportunistic Insights Fund | 40457 | 31 July, 2020 | 0.04 |
| Rydex Biotechnology Fund | 37905 | 31 July, 2020 | 1.12 |
| Hartford Small Company HLS Fund, Inc. | 37886 | 31 July, 2020 | 0.61 |
| CREF Equity Index Account | 36433 | 31 July, 2020 | 0.01 |
| Franklin Templeton VIPT Franklin Small-Mid Cap Growth VIP Fund | 36000 | 31 July, 2020 | 0.49 |
| MassMutual Select Small Cap Growth Equity Fund | 35035 | 31 July, 2020 | 0.41 |
| Fidelity NASDAQ Composite Index Fund | 33961 | 31 July, 2020 | 0.02 |
| TIAA-CREF Large Cap Growth Index Fund | 33251 | 31 July, 2020 | 0.03 |
| Columbia Multi-Manager Small Cap Equity Strategies Fund | 30343 | 31 July, 2020 | 0.17 |
| Vanguard Russell 1000 Growth Index Fund | 29167 | 31 July, 2020 | 0.03 |
| Hartford Healthcare HLS Fund | 28729 | 31 July, 2020 | 0.9 |
| Driehaus Micro Cap Growth Fund | 27329 | 31 July, 2020 | 0.7 |
| Thrivent Moderate Allocation Fund | 26341 | 31 July, 2020 | 0.06 |
| BNY Mellon Select Managers Small Cap Growth Fund | 24097 | 31 July, 2020 | 0.3 |
| Thrivent Moderately Aggressive Allocation Fund | 23464 | 31 July, 2020 | 0.07 |
| Fidelity Advisor Equity Growth Fund | 22500 | 31 July, 2020 | 0.04 |
| EQ/Fidelity Institutional AM Large Cap Port | 22387 | 31 July, 2020 | 0.18 |
| John Hancock Funds II - Health Sciences Fund | 22197 | 31 July, 2020 | 0.36 |
| John Hancock VIT Small Cap Stock Trust | 22031 | 31 July, 2020 | 0.49 |
| Schwab Total Stock Market Index Fund | 21893 | 31 July, 2020 | 0.01 |
| GAM Multistock - Health Innovation Equity | 21600 | 31 July, 2020 | 1.1 |
| Driehaus Small Cap Growth Fund | 21383 | 31 July, 2020 | 0.61 |
| Nuveen Small Cap Growth Opportunities Fund | 21214 | 31 July, 2020 | 0.69 |
| DWS Small Cap Growth Fund | 21100 | 31 July, 2020 | 0.44 |
| Vanguard US Equity Index Fund | 20470 | 31 July, 2020 | 0.01 |
| Vanguard Total World Stock Index Fund | 19744 | 31 July, 2020 | 0.01 |
| Schwab 1000 Index Fund | 19722 | 31 July, 2020 | 0.01 |
| JPM Small Cap Blend Fund | 19580 | 31 July, 2020 | 0.27 |
| Invesco V.I. Health Care Fund | 18055 | 31 July, 2020 | 0.58 |
| Fidelity Large Cap Growth Index Fund | 17438 | 31 July, 2020 | 0.02 |
| VALIC Company II - Small Cap Growth Fund | 16977 | 31 July, 2020 | 0.63 |
| John Hancock VIT - Health Sciences Trust | 15232 | 31 July, 2020 | 0.36 |
| Fidelity Growth Discovery Fund | 15000 | 31 July, 2020 | 0.04 |
| AB Small Cap Core Portfolio | 14330 | 31 July, 2020 | 0.11 |
| Columbia Active Portfolios - Multi-Manager Growth Fund | 14203 | 31 July, 2020 | 0.03 |
| DWS Health and Wellness Fund | 13724 | 31 July, 2020 | 0.3 |
| BNP Paribas Funds US Mid Cap | 13099 | 31 July, 2020 | 0.73 |
| Fidelity NASDAQ Composite Index Tracking Stock | 12381 | 31 July, 2020 | 0.03 |
| Nicholas Partners Small Cap Growth Fund | 12077 | 31 July, 2020 | 1.22 |
| Thrivent Moderately Aggressive Allocation Portfolio | 11481 | 31 July, 2020 | 0.04 |
| CREF Growth Account | 11258 | 31 July, 2020 | N/A |
| Nationwide NVIT Multi-Manager Small Company Fund | 11257 | 31 July, 2020 | 0.28 |
| Fidelity ZERO Total Market Index Fund | 11195 | 31 July, 2020 | 0.01 |
| Driehaus US Small Cap Equity Fund | 11143 | 31 July, 2020 | 0.61 |
| ProShares Ultra Nasdaq Biotechnology | 10902 | 31 July, 2020 | 0.45 |
| EQ/Large Cap Growth Managed Volatility Port | 10362 | 31 July, 2020 | 0.01 |
| EQ/T Rowe Price Health Sciences Portfolio | 10332 | 31 July, 2020 | 0.36 |
| Fidelity VIP Growth Opportunities Portfolio | 10300 | 31 July, 2020 | 0.03 |
| Allianz Biotechnologie | 10040 | 31 July, 2020 | 0.19 |
| Adara Smaller Companies Fund | 10693 | 30 June, 2020 | 0.22 |
| Fidelity Insights Class | 16552 | 30 June, 2020 | 0.03 |
| Janus Henderson US Venture Fund | 15010 | 30 June, 2020 | 0.57 |
| Janus Henderson Global Research Portfolio | 29778 | 30 June, 2020 | 0.27 |
| Janus Henderson Global Life Sciences Fund (Ire) | 456621 | 30 June, 2020 | 1.04 |
| T. Rowe Price Extended Equity Market Index Fund | 15000 | 30 June, 2020 | 0.11 |
| Pyramis US Small/Mid Cap Core Trust | 11720 | 30 June, 2020 | 0.97 |
| Janus Henderson Research Portfolio | 27097 | 30 June, 2020 | 0.31 |
| GuideStone Small Cap Equity Fund | 26400 | 30 June, 2020 | 0.31 |
| ERShares US Small Cp Fund | 26362 | 30 June, 2020 | 1.02 |
| Voya SmallCap Opportunities Portfolio | 14361 | 30 June, 2020 | 0.33 |
| United Global Healthcare Fund (Singapore) | 26152 | 30 June, 2020 | 0.55 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 462058 | 30 June, 2020 | 0.66 |
| Optimum Small-Mid Cap Growth Fund | 24278 | 30 June, 2020 | 0.28 |
| Brown Advisory Small-Cap Growth Fund | 185303 | 30 June, 2020 | 0.75 |
| Wellington Global Healthcare Equity Fund | 259253 | 30 June, 2020 | 0.54 |
| American Funds SMALLCAP World Fund | 467520 | 30 June, 2020 | 0.06 |
| Fidelity Insights Investment Trust | 23545 | 30 June, 2020 | 0.03 |
| Morgan Stanley Pathway Funds Small-Mid Cap Equity Fund | 11648 | 30 June, 2020 | 0.13 |
| American Funds Insurance Series Growth Fund | 125000 | 30 June, 2020 | 0.03 |
| Met Inv. Ser. Trust WMC Large Cap Research Portfolio | 23333 | 30 June, 2020 | 0.07 |
| DekaLux-BioTech | 22550 | 30 June, 2020 | 0.43 |
| Fidelity Global Disciplined Equity Fund | 11500 | 30 June, 2020 | 0.44 |
| T. Rowe Price Health Sciences Fund | 807881 | 30 June, 2020 | 0.37 |
| American Funds New Economy Fund | 305000 | 30 June, 2020 | 0.09 |
| Voya SmallCap Opportunities Fund | 13275 | 30 June, 2020 | 0.33 |
| KP Small Cap Equity Fund;Instl | 13115 | 30 June, 2020 | 0.07 |
| American Century Small Cap Growth Fund | 79814 | 30 June, 2020 | 0.42 |
| T Rowe Price Spectrum Mod Growth Alloc Fund | 21608 | 30 June, 2020 | 0.05 |
| Voya Russell Mid Cap Growth Index Portfolio | 13071 | 30 June, 2020 | 0.14 |
| Brighthouse Funds Trust II -T. Rowe Price Small Cap Growth Portfolio | 69087 | 30 June, 2020 | 0.34 |
| Candriam Equities L Biotechnology | 67843 | 30 June, 2020 | 0.24 |
| Vanguard Global Small-Cap Index Fund | 20709 | 30 June, 2020 | 0.06 |
| T Rowe Price PF - US Smaller Companies Equity | 56173 | 30 June, 2020 | 0.26 |
| TD Health Sciences Fund | 56062 | 30 June, 2020 | 0.38 |
| T. Rowe Price New Horizons Fund | 809239 | 30 June, 2020 | 0.17 |
| Aviva Investors Multi-Strategy Target Return Fund | 20047 | 30 June, 2020 | 0.07 |
| Espa Stock Biotec | 53500 | 30 June, 2020 | 1.15 |
| T Rowe Price Spectrum Moderate Allocation Fund | 12712 | 30 June, 2020 | 0.04 |
| T. Rowe Price Small Cap Stock Fund | 869981 | 30 June, 2020 | 0.66 |
| Voya Small Company Fund | 19560 | 30 June, 2020 | 0.33 |
| Russell Investments U.S. Small Cap Equity Fund | 19458 | 30 June, 2020 | 0.1 |
| VALIC Co I Health Sciences Fund | 49114 | 30 June, 2020 | 0.37 |
| Voya VP Small Company Portfolio | 19024 | 30 June, 2020 | 0.33 |
| Putnam Small Cap Growth Fund | 47050 | 30 June, 2020 | 0.55 |
| Fidelity American Disciplined Equity Fund | 44200 | 30 June, 2020 | 0.47 |
| Brown Advisory US Smaller Companies B USD | 43827 | 30 June, 2020 | 0.68 |
| American Funds Growth Fund of America | 550000 | 30 June, 2020 | N/A |
| BankInvest USA Small Cap Aktier | 12530 | 30 June, 2020 | 0.87 |
| JNL/Mellon Capital Healthcare Sector Fund | 40440 | 30 June, 2020 | 0.08 |
| T. Rowe Price Health Sciences Portfolio | 38154 | 30 June, 2020 | 0.39 |
| Brown Advisory US Small Cap Blend Fund | 10248 | 30 June, 2020 | 0.34 |
| T Rowe Price QM US Small-Cap Growth Equity Fund | 437390 | 30 June, 2020 | 0.33 |
| TD U.S. Small-Cap Equity Fund | 37666 | 30 June, 2020 | 0.66 |
| Brown Advisory US Mid-Cap Growth Fund | 15596 | 30 June, 2020 | 0.32 |
| Wellington Us Research Equity | 33766 | 30 June, 2020 | 0.08 |
| BlackRock Advantage Small Cap Core Fund | 32530 | 30 June, 2020 | 0.16 |
| BlackRock Health Sciences Trust II | 82931 | 31 May, 2020 | 0.23 |
| JPM US Small Cap Growth Fund | 28498 | 31 May, 2020 | 0.65 |
| Fidelity Strategic Advisers Small-Mid Cap Fund | 87375 | 31 May, 2020 | 0.08 |
| Destinations Small-Mid Cap Equity Fund | 36675 | 31 May, 2020 | 0.31 |
| Fidelity Advisor Series Small Cap Fund | 19800 | 31 May, 2020 | 0.35 |
| Invesco Global Health Care Innovation | 31055 | 31 May, 2020 | 0.64 |
| Fidelity Small Cap Enhanced Index Fund | 12719 | 31 May, 2020 | 0.2 |
| Fidelity Advisor Small Cap Fund | 88900 | 31 May, 2020 | 0.43 |
| New Capital US Small Cap Growth Fund | 18787 | 31 May, 2020 | 1.5 |
| UBS (CH) Inst Fd 2-Eq Global Small Cap Passive II | 20980 | 31 May, 2020 | 0.08 |
| JPMorgan Funds - US Small Cap Growth Fund | 32174 | 31 May, 2020 | 0.65 |
| DFA U.S. Vector Equity Portfolio | 12976 | 30 April, 2020 | 0.03 |
| DFA T.A. U.S. Core Equity 2 Portfolio | 20775 | 30 April, 2020 | 0.02 |
| DFA Tax-Managed U.S. Small Cap Portfolio | 25304 | 30 April, 2020 | 0.08 |
| Fidelity Small Cap Growth Fund | 585981 | 30 April, 2020 | 1.35 |
| DFA U.S. Core Equity 1 Portfolio | 83768 | 30 April, 2020 | 0.03 |
| Fidelity Small Cap Index Fund | 346714 | 30 April, 2020 | 0.27 |
| Fidelity Small Cap Growth K6 Fund | 139345 | 30 April, 2020 | 1.37 |
| Goldman Sachs Small Cap Growth Insights Fund | 97391 | 30 April, 2020 | 0.78 |
| DFA U.S. Core Equity 2 Portfolio | 98361 | 30 April, 2020 | 0.03 |
| DFA U.S. Small Cap Portfolio | 116161 | 30 April, 2020 | 0.07 |
| CIBC Atlas Mid Cap Equity Fund | 50592 | 30 April, 2020 | 0.59 |
| Goldman Sachs Small Cap Equity Insights Fund | 38503 | 30 April, 2020 | 0.53 |
| Schroder Unit Trusts Limited Global Healthcare Fund | 31696 | 30 April, 2020 | 0.65 |
| Janus Henderson Henderson Research Fund | 753333 | 31 March, 2020 | 0.31 |
| Janus Henderson Triton Fund | 955709 | 31 March, 2020 | 0.62 |
| MainStay VP Small Cap Growth Portfolio | 30399 | 31 March, 2020 | 0.42 |
| Tekla Healthcare Investors | 77990 | 31 March, 2020 | 0.5 |
| Janus Henderson Global Life Sciences Fund (US) | 772433 | 31 March, 2020 | 1.25 |
| Florida State Board Administration Fund | 34239 | 31 March, 2020 | N/A |
| Bridge Builder Small/Mid Cap Growth Fund | 27037 | 31 March, 2020 | 0.04 |
| ON BlackRock Advantage Small Cap Growth Portfolio | 13006 | 31 March, 2020 | 0.46 |
| ON Janus Henderson Venture Portfolio | 14341 | 31 March, 2020 | 0.61 |
| Tekla Life Sciences Investors | 40093 | 31 March, 2020 | 0.57 |
| Janus Henderson Venture Fund | 302757 | 31 March, 2020 | 0.64 |
| Mutual of America Small Cap Growth Fund | 45725 | 31 March, 2020 | 0.57 |
| Janus Henderson Global Research Fund | 138163 | 31 March, 2020 | 0.3 |
| Stichting Pensioenfonds ABP | 410161 | 31 March, 2020 | 0.01 |
| Eventide Healthcare & Life Sciences Fund | 535000 | 31 March, 2020 | 2.92 |
| Renaissance Global Health Care Fund | 37854 | 31 March, 2020 | 0.45 |
| Pictet-Biotech | 397998 | 29 February, 2020 | 2.03 |
| AM-One Medical Science Fund | 54787 | 31 January, 2020 | 1.04 |
| Anima Selezione Globale | 81400 | 31 December, 2019 | 0.72 |
| Anima Magellano | 47700 | 31 December, 2019 | 0.53 |
| Anima Fondo Trading | 70000 | 31 December, 2019 | 1.12 |
| Polar Capital Biotechnology Fund | 75000 | 31 December, 2019 | N/A |
| Wellington Global Health Care Long-Short Fund | 17570 | 31 December, 2019 | 2.74 |
| Anima Valore Globale | 95851 | 31 December, 2019 | 0.64 |
| Nomura World Genome Technology Open A Course | 129894 | 30 November, 2019 | N/A |
| Goldman Sachs Multi-Manager US Sm Cp Eqty | 10980 | 30 April, 2019 | N/A |
| British Columbia Investment Management Corp | 18831 | 31 March, 2019 | N/A |
| SOROS FUND MANAGEMENT LLC | 21000 | 16 February, 2016 | N/A |
| Symbol | Transaction Date | Reporting Cik | Securities Owned | Company Cik | Reporting Name | Acquistion Or Disposition | Form Type | Securities Transacted | Security Name | Link |
|---|---|---|---|---|---|---|---|---|---|---|
| GBT | 1 August, 2022 | 0001405253 | 9060 | 0001629137 | Farrow Jeffrey S | D | 4 | 3020 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001405253 | 3125 | 0001629137 | Farrow Jeffrey S | D | 4 | 3125 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001405253 | 31441 | 0001629137 | Farrow Jeffrey S | D | 4 | 2126 | Common Stock | View |
| GBT | 1 August, 2022 | 0001405253 | 33567 | 0001629137 | Farrow Jeffrey S | A | 4 | 6145 | Common Stock | View |
| GBT | 1 August, 2022 | 0001733883 | 10935 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 3645 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001733883 | 3125 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 3125 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001733883 | 53151 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 2342 | Common Stock | View |
| GBT | 1 August, 2022 | 0001733883 | 55493 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 6770 | Common Stock | View |
| GBT | 1 August, 2022 | 0001650126 | 9060 | 0001629137 | Choi Jung | D | 4 | 3020 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001650126 | 3125 | 0001629137 | Choi Jung | D | 4 | 3125 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001650126 | 197928 | 0001629137 | Choi Jung | D | 4 | 2126 | Common Stock | View |
| GBT | 1 August, 2022 | 0001650126 | 200054 | 0001629137 | Choi Jung | A | 4 | 6145 | Common Stock | View |
| GBT | 1 August, 2022 | 0001188919 | 26865 | 0001629137 | LOVE TED W | D | 4 | 8955 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001188919 | 11250 | 0001629137 | LOVE TED W | D | 4 | 11250 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001188919 | 805174 | 0001629137 | LOVE TED W | D | 4 | 10018 | Common Stock | View |
| GBT | 1 August, 2022 | 0001188919 | 815192 | 0001629137 | LOVE TED W | A | 4 | 20205 | Common Stock | View |
| GBT | 1 August, 2022 | 0001913961 | 1746 | 0001629137 | Habibizad Nazila | D | 4 | 581 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001913961 | 938 | 0001629137 | Habibizad Nazila | D | 4 | 937 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001913961 | 13596 | 0001629137 | Habibizad Nazila | D | 4 | 526 | Common Stock | View |
| GBT | 1 August, 2022 | 0001913961 | 14122 | 0001629137 | Habibizad Nazila | A | 4 | 1518 | Common Stock | View |
| GBT | 1 August, 2022 | 0001238408 | 9060 | 0001629137 | SUVARI TRICIA BORGA | D | 4 | 3020 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001238408 | 3125 | 0001629137 | SUVARI TRICIA BORGA | D | 4 | 3125 | Restricted Stock Units | View |
| GBT | 1 August, 2022 | 0001238408 | 39602 | 0001629137 | SUVARI TRICIA BORGA | D | 4 | 2126 | Common Stock | View |
| GBT | 1 August, 2022 | 0001238408 | 41728 | 0001629137 | SUVARI TRICIA BORGA | A | 4 | 6145 | Common Stock | View |
| GBT | 21 June, 2022 | 0001574579 | 5376 | 0001629137 | Svoronos Dawn | D | 4 | 1908 | Common Stock | View |
| GBT | 21 June, 2022 | 0001574286 | 9112 | 0001629137 | Pizzo Philip A. | D | 4 | 1260 | Common Stock | View |
| GBT | 14 June, 2022 | 0001190270 | 3600 | 0001629137 | PERRY MARK L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001190270 | 5600 | 0001629137 | PERRY MARK L | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001190270 | 0 | 0001629137 | PERRY MARK L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001190270 | 37865 | 0001629137 | PERRY MARK L | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001053466 | 3600 | 0001629137 | PATRICK DEVAL L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001053466 | 5600 | 0001629137 | PATRICK DEVAL L | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001053466 | 0 | 0001629137 | PATRICK DEVAL L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001053466 | 9037 | 0001629137 | PATRICK DEVAL L | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001181186 | 3600 | 0001629137 | YARNO WENDY L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001181186 | 5600 | 0001629137 | YARNO WENDY L | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001181186 | 0 | 0001629137 | YARNO WENDY L | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001181186 | 11437 | 0001629137 | YARNO WENDY L | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001662426 | 3600 | 0001629137 | Morrison Scott W | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001662426 | 5600 | 0001629137 | Morrison Scott W | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001662426 | 0 | 0001629137 | Morrison Scott W | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001662426 | 6637 | 0001629137 | Morrison Scott W | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001574579 | 3600 | 0001629137 | Svoronos Dawn | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001574579 | 5600 | 0001629137 | Svoronos Dawn | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001574579 | 0 | 0001629137 | Svoronos Dawn | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001574579 | 7284 | 0001629137 | Svoronos Dawn | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001574286 | 3600 | 0001629137 | Pizzo Philip A. | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001574286 | 5600 | 0001629137 | Pizzo Philip A. | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001574286 | 0 | 0001629137 | Pizzo Philip A. | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001574286 | 10372 | 0001629137 | Pizzo Philip A. | A | 4 | 3600 | Common Stock | View |
| GBT | 14 June, 2022 | 0001851895 | 3600 | 0001629137 | Thompson Alexis A. | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001851895 | 5600 | 0001629137 | Thompson Alexis A. | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001851895 | 0 | 0001629137 | Thompson Alexis A. | A | 4 | 908 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001851895 | 3308 | 0001629137 | Thompson Alexis A. | A | 4 | 908 | Common Stock | View |
| GBT | 14 June, 2022 | 0001256964 | 3600 | 0001629137 | PIERCE GLENN | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001256964 | 5600 | 0001629137 | PIERCE GLENN | A | 4 | 5600 | Stock Option (Right to Buy) | View |
| GBT | 14 June, 2022 | 0001256964 | 0 | 0001629137 | PIERCE GLENN | A | 4 | 3600 | Restricted Stock Units | View |
| GBT | 14 June, 2022 | 0001256964 | 26437 | 0001629137 | PIERCE GLENN | A | 4 | 3600 | Common Stock | View |
| GBT | 1 June, 2022 | 0001860297 | 18120 | 0001629137 | Smith-Whitley Kim | D | 4 | 6040 | Restricted Stock Units | View |
| GBT | 1 June, 2022 | 0001860297 | 4380 | 0001629137 | Smith-Whitley Kim | D | 4 | 1660 | Common Stock | View |
| GBT | 1 June, 2022 | 0001860297 | 6040 | 0001629137 | Smith-Whitley Kim | A | 4 | 6040 | Common Stock | View |
| GBT | 1 April, 2022 | 0001733883 | 0 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 4375 | Restricted Stock Units | View |
| GBT | 1 April, 2022 | 0001733883 | 48424 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 1513 | Common Stock | View |
| GBT | 1 April, 2022 | 0001733883 | 49937 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 4375 | Common Stock | View |
| GBT | 1 April, 2022 | 0001913961 | 730 | 0001629137 | Habibizad Nazila | D | 4 | 183 | Restricted Stock Units | View |
| GBT | 1 April, 2022 | 0001913961 | 4125 | 0001629137 | Habibizad Nazila | D | 4 | 1375 | Restricted Stock Units | View |
| GBT | 1 April, 2022 | 0001913961 | 30036 | 0001629137 | Habibizad Nazila | D | 4 | 540 | Common Stock | View |
| GBT | 1 April, 2022 | 0001913961 | 30576 | 0001629137 | Habibizad Nazila | A | 4 | 1558 | Common Stock | View |
| GBT | 17 March, 2022 | 0001851895 | 4800 | 0001629137 | Thompson Alexis A. | D | 4 | 2400 | Restricted Stock Units | View |
| GBT | 17 March, 2022 | 0001851895 | 2400 | 0001629137 | Thompson Alexis A. | A | 4 | 2400 | Common Stock | View |
| GBT | 1 March, 2022 | 0001913961 | 28628 | 0001629137 | Habibizad Nazila | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001913961 | 17668 | 0001629137 | Habibizad Nazila | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001913961 | 10023 | 0001629137 | Habibizad Nazila | A | 4 | 1671 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001913961 | 29018 | 0001629137 | Habibizad Nazila | D | 4 | 613 | Common Stock | View |
| GBT | 1 March, 2022 | 0001913961 | 29631 | 0001629137 | Habibizad Nazila | A | 4 | 1671 | Common Stock | View |
| GBT | 1 March, 2022 | 0001733883 | 28628 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001733883 | 17668 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001733883 | 16577 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 2763 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001733883 | 45562 | 0001629137 | JOHNSON DAVID LEE | D | 4 | 956 | Common Stock | View |
| GBT | 1 March, 2022 | 0001733883 | 46518 | 0001629137 | JOHNSON DAVID LEE | A | 4 | 2763 | Common Stock | View |
| GBT | 1 March, 2022 | 0001238408 | 28628 | 0001629137 | SUVARI TRICIA BORGA | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001238408 | 17668 | 0001629137 | SUVARI TRICIA BORGA | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001238408 | 16577 | 0001629137 | SUVARI TRICIA BORGA | A | 4 | 2763 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001238408 | 35653 | 0001629137 | SUVARI TRICIA BORGA | D | 4 | 956 | Common Stock | View |
| GBT | 1 March, 2022 | 0001238408 | 36609 | 0001629137 | SUVARI TRICIA BORGA | A | 4 | 2763 | Common Stock | View |
| GBT | 1 March, 2022 | 0001650126 | 28628 | 0001629137 | Choi Jung | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001650126 | 17668 | 0001629137 | Choi Jung | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001650126 | 16577 | 0001629137 | Choi Jung | A | 4 | 2763 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001650126 | 191374 | 0001629137 | Choi Jung | D | 4 | 956 | Common Stock | View |
| GBT | 1 March, 2022 | 0001650126 | 192330 | 0001629137 | Choi Jung | A | 4 | 2763 | Common Stock | View |
| GBT | 1 March, 2022 | 0001823899 | 28628 | 0001629137 | Krehlik Carrie | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001823899 | 17668 | 0001629137 | Krehlik Carrie | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001860297 | 28628 | 0001629137 | Smith-Whitley Kim | A | 4 | 28628 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001860297 | 17668 | 0001629137 | Smith-Whitley Kim | A | 4 | 17668 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001188919 | 118090 | 0001629137 | LOVE TED W | A | 4 | 118090 | Stock Option (Right to buy) | View |
| GBT | 1 March, 2022 | 0001188919 | 72877 | 0001629137 | LOVE TED W | A | 4 | 72877 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001188919 | 56667 | 0001629137 | LOVE TED W | A | 4 | 9445 | Restricted Stock Units | View |
| GBT | 1 March, 2022 | 0001188919 | 794987 | 0001629137 | LOVE TED W | D | 4 | 4074 | Common Stock | View |
| GBT | 1 March, 2022 | 0001188919 | 799061 | 0001629137 | LOVE TED W | A | 4 | 9445 | Common Stock | View |
| GBT | 1 March, 2022 | 0001405253 | 28628 | 0001629137 | Farrow Jeffrey S | A | 4 | 28628 | Stock Option (Right to buy) | View |
Charts
Company Historical Earnings
| Date | Symbol | EPS | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|---|---|
| 8 August, 2022 | GBT | -1.26 | -1.26 | amc | 0 | 64390000 |
| 4 May, 2022 | GBT | -1.26 | -1.26 | amc | 55160000 | 56857230 |
| 23 February, 2022 | GBT | -1.36 | -1.36 | amc | 56099000 | 55040000 |
| 4 November, 2021 | GBT | -1.13 | -1.13 | amc | 52052000 | 53510000 |
| 3 August, 2021 | GBT | -1.12 | -1.12 | amc | 47555000 | 43920000 |
| 5 May, 2021 | GBT | -1.21 | -1.21 | amc | 39043000 | 43460000 |
| 24 February, 2021 | GBT | -1 | -1 | amc | 41295000 | 39530000 |
| 5 November, 2020 | GBT | -0.97 | -0.97 | amc | 36889000 | 27761824.742268 |
| 5 August, 2020 | GBT | -0.86 | -0.86 | amc | 31501000 | 42123430.232558 |
| 6 May, 2020 | GBT | -1.2 | -1.2 | amc | 14118000 | 17765150 |
| 26 February, 2020 | GBT | -1.59 | -1.59 | amc | 2108000 | 1643974.8427673 |
| 7 November, 2019 | GBT | -1.07 | -1.07 | bmo | 0 | 0 |
| 7 August, 2019 | GBT | -1.01 | -1.01 | bmo | 0 | 0 |
| 8 May, 2019 | GBT | -0.87 | -0.87 | bmo | 0 | 0 |
| 27 February, 2019 | GBT | -0.93 | -0.93 | bmo | 0 | 0 |
| 6 November, 2018 | GBT | -0.83 | -0.83 | bmo | 0 | 0 |
| 2 August, 2018 | GBT | -0.78 | -0.78 | bmo | 0 | 0 |
| 7 May, 2018 | GBT | -0.87 | -0.87 | bmo | 0 | 0 |
| 27 February, 2018 | GBT | -0.94 | -0.94 | bmo | 0 | 0 |
| 2 November, 2017 | GBT | -0.66 | -0.66 | bmo | 0 | 0 |
| 7 August, 2017 | GBT | -0.55 | -0.55 | bmo | 0 | 0 |
| 1 May, 2017 | GBT | -0.6 | -0.6 | bmo | 0 | 0 |
| 13 March, 2017 | GBT | -0.74 | -0.74 | bmo | 0 | 0 |
| 9 November, 2016 | GBT | -0.58 | -0.58 | bmo | 0 | 0 |
| 10 August, 2016 | GBT | -0.58 | -0.58 | bmo | 0 | 0 |
| 12 May, 2016 | GBT | -0.56 | -0.56 | bmo | 0 | 0 |
| 29 March, 2016 | GBT | -0.53 | -0.53 | bmo | 0 | 0 |
| 12 November, 2015 | GBT | -0.9 | -0.9 | bmo | 0 | 0 |
| 24 September, 2015 | GBT | -4.84 | -4.84 | bmo | 0 | 0 |
| 17 August, 2015 | GBT | bmo | 0 | 0 |
Company Profile
Company Name Global Blood Therapeutics, Inc.
Symbol GBT
Currency USD
Price 66.71
Exchange Name NASDAQ Global Select (NASDAQ)
Industry Biotechnology
Website https://www.gbt.com
CEO Dr. Ted Love
Sector Healthcare
Country US
Full Time Employees 457
Phone 16507417700
Address 181 OYSTER POINT BLVD
City South San Francisco
State CALIFORNIA
Zip 94080
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
